|Bid||115.89 x 800|
|Ask||116.03 x 800|
|Day's Range||114.15 - 119.20|
|52 Week Range||35.25 - 141.90|
|Beta (5Y Monthly)||1.89|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.
Exact Sciences look set to have a three-weeks-tight pattern. The company is one of several working on liquid biopsies, with blood tests that can detect multiple cancers. It's the subject of our IBD Cover story this week.
Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Illumina, Exact Sciences deals heating up a game-changing field in cancer treatment.